Biologics and Biosimilars market

Biologics and Biosimilars Market, Global Outlook and Forecast 2023-2029

  • 17 March 2023
  • Life Sciences
  • 112 Pages
  • Report code : PMR-7604307

  • 4.7 (158)

Biologics and Biosimilars Market

Download FREE Report Sample

  Download Free sample

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In Biologics and Biosimilars Market is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

A biosimilar in Biologics and Biosimilars Market is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ?innovator? products, and can be manufactured when the original product's patent expires.

Biologics and Biosimilars Market aims to provide a comprehensive presentation of the global market for Biologics and Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics and Biosimilars. Biologics and Biosimilars Market contains market size and forecasts of Biologics and Biosimilars in global, including the following market information:

Global Biologics and Biosimilars Market Revenue, 2018-2023, 2024-2029, ($ millions)

Global Biologics and Biosimilars Market Sales, 2018-2023, 2024-2029, (K Units)

Global top five Biologics and Biosimilars companies in 2022 (%)

The global Biologics and Biosimilars market was valued at US$ 198790 million in 2022 and is projected to reach US$ 277500 million by 2029, at a CAGR of 4.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The major global manufacturers of biologics and biosimilars are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, Sansheng Pharmaceuticals, Changchun Gaoxin, CITICS Guojia, Baitai Biotech, Sijin Biotech, Cinda Biotech, Tonghua Dongbao, Ganli and Union Pharmaceuticals, etc. Roche, Amgen and AbbVie are the top three, with a combined market share of about 37%.

We surveyed the Biologics and Biosimilars manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biologics and Biosimilars Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Biologics and Biosimilars Market Segment Percentages, by Type, 2022 (%)

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Others

Global Biologics and Biosimilars Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Biologics and Biosimilars Market Segment Percentages, by Application, 2022 (%)

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Global Biologics and Biosimilars Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)

Global Biologics and Biosimilars Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biologics and Biosimilars revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Biologics and Biosimilars revenues share in global market, 2022 (%)

Key companies Biologics and Biosimilars sales in global market, 2018-2023 (Estimated), (K Units)

Key companies Biologics and Biosimilars sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Outline of Major Chapters:

Chapter 1: Introduces the definition of Biologics and Biosimilars, market overview.

Chapter 2: Global Biologics and Biosimilars market size in revenue and volume.

Chapter 3: Detailed analysis of Biologics and Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biologics and Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Global Biologics and Biosimilars capacity by region & country.

Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 11: The main points and conclusions of the report.

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Biologics and Biosimilars Market

Leave This Empty: